Antitumor effect and pharmacokinetics of intraperitoneal NK105, a nanomicellar paclitaxel for peritoneal dissemination

Cancer Science, 03/21/2012

Intraperitoneal chemotherapy with nanoparticulate paclitaxel NK105 may offer a novel treatment strategy for improving drug delivery in gastric cancer with peritoneal dissemination because of enhanced drug penetration into peritoneal nodules and prolonged systemic circulation.

Print Article Summary Cat 2 CME Report